Form 4: Edwards Lifesciences CFO Scott B. Ullem Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Scott B. Ullem, CFO of Edwards Lifesciences, reports changes in beneficial ownership of company stock, including the disposal of 1,200 shares to cover tax obligations.
Summary
- On May 11, 2025, Scott B. Ullem, the Chief Financial Officer of Edwards Lifesciences Corp, reported changes in his beneficial ownership of the company's common stock.
- He disposed of 1,200 shares of common stock at a price of $73.68 per share to satisfy tax obligations.
- Following the transaction, Ullem directly owns 39,898 shares of Edwards Lifesciences common stock.
- Ullem also indirectly owns 266,318 shares through a trust.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the document simply reports a routine transaction by a company insider to cover tax obligations. It doesn't indicate any significant positive or negative developments for the company.
Industry Context
Form 4 filings are a routine part of regulatory compliance for corporate insiders and provide transparency into their trading activities. This filing indicates a transaction by the CFO of Edwards Lifesciences, a major player in the medical device industry.
Key Dates
| Date | Description |
|---|---|
| 05/11/2025 | Date of transaction: disposal of 1,200 shares of common stock. |
| 05/12/2025 | Date of signature by Attorney-in-Fact, Linda J. Park. |
Keywords
Form 4, Beneficial Ownership, Edwards Lifesciences, Scott B. Ullem, CFO, Stock Transaction, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.